Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
β Scribed by Jia Xu, Priya B Shetty, Weiwei Feng, Carol Chenault, Robert C Bast Jr, Jean-Pierre J Issa, Susan G Hilsenbeck, Yinhua Yu
- Book ID
- 119897308
- Publisher
- BioMed Central
- Year
- 2012
- Tongue
- English
- Weight
- 195 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1471-2407
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Aberrant methylation is a main mechanism of tumor suppressor gene inactivation in carcinogenesis. In this study, the methylation status of __RASSF1A__, __p16__, __MLH1__, __MSH2__ and __ERΞ±__ was investigated in 84 primary soft tissue sarcomas (STSs), including 22 liposarcomas, 18 malig
## Abstract Idβ1 is an important regulator of cellular growth and differentiation and controls malignant progression of breast cancer cells. The aim of our study was to assess the clinical impact of Idβ1 expression in breast cancer, __i.e.__, its potential impact on prognosis and prediction of trea